Solutions
TwinRCTs I
TwinRCTs II
Technology
Digital Twins
DTGs
Solutions
Technology
About
Careers
Resources
Blog
Contact
Button
Button
Announcement
All content
All content
Link 1
All content
All content
Link 1
CISION PR Newswire
Announcement
Mira Murati, CTO of OpenAI, Joins Unlearn.AI's Board of Directors
Read more
CISION PR Newswire
Announcement
Mira Murati, CTO of OpenAI, Joins Unlearn.AI's Board of Directors
Read more
Business Wire
Announcement
Unlearn Appoints Alex Lang, Ph.D. as Vice President, Technology
Read more
Business Wire
Announcement
Unlearn Appoints Alex Lang, Ph.D. as Vice President, Technology
Read more
Business Wire
Announcement
European Medicines Agency Qualifies Unlearn’s AI-powered Method for Running Smaller, Faster Clinical Trials
Read more
Business Wire
Announcement
European Medicines Agency Qualifies Unlearn’s AI-powered Method for Running Smaller, Faster Clinical Trials
Read more
Business Wire
Announcement
Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs™ in Clinical Trials
Read more
Business Wire
Announcement
Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs™ in Clinical Trials
Read more
Business Wire
Announcement
Unlearn Receives Draft Qualification Opinion from European Medicines Agency for Using the PROCOVA™ Framework to Implement TwinRCTs™
Read more
Business Wire
Announcement
Unlearn Receives Draft Qualification Opinion from European Medicines Agency for Using the PROCOVA™ Framework to Implement TwinRCTs™
Read more
Business Wire
Announcement
Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™
Read more
Business Wire
Announcement
Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™
Read more
Business Wire
Announcement
Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development
Read more
Business Wire
Announcement
Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development
Read more
Business Wire
Announcement
Unlearn Appoints Arman Sabbaghi, Ph.D. as Head of Biostatistics Research
Read more
Business Wire
Announcement
Unlearn Appoints Arman Sabbaghi, Ph.D. as Head of Biostatistics Research
Read more
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
